Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000643494 | SCV000765181 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-11-17 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000733576 | SCV000861655 | uncertain significance | not provided | 2018-06-08 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002493015 | SCV002787890 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-08-12 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000733576 | SCV003824960 | uncertain significance | not provided | 2023-10-27 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003150314 | SCV003838547 | uncertain significance | Cardiomyopathy | 2021-07-21 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000733576 | SCV001744138 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000733576 | SCV001920065 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000733576 | SCV001932957 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000733576 | SCV001955245 | uncertain significance | not provided | no assertion criteria provided | clinical testing |